Ultra-sensitive protein chip and kit for detecting main glycoprotein of pneumocystis cell wall

An ultra-sensitive protein chip with optimized capture molecule dispersion and monoclonal antibodies addresses the sensitivity issue in Pneumocystis pneumonia detection, enabling rapid and accurate diagnosis at low antigen levels.

CN119064594APending Publication Date: 2024-12-03BEIJING YOUAN HOSPITAL CAPITAL MEDICAL UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411177424.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-26
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

Current methods for detecting Pneumocystis pneumonia are not sensitive enough to detect low levels of Pneumocystis antigen in patient samples, hindering early diagnosis.

Method used

An ultra-sensitive protein chip with dispersed capture molecules and specific monoclonal antibodies, optimized for detecting Pneumocystis cell wall glycoproteins at the picogram level, using a coating density of 5x10 per square millimeter and a diameter of 3-5 mm detection spots, with Teflon separation to prevent cross-contamination.

Benefits of technology

The chip achieves rapid, accurate, and economical detection of Pneumocystis glycoproteins at 1.8 pg/ml, improving early diagnosis of Pneumocystis pneumonia with high sensitivity and specificity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119064594A_ABST
    Figure CN119064594A_ABST
Patent Text Reader

Abstract

The invention provides an ultra-sensitive protein chip for detecting main glycoprotein of pneumocystis cell wall, which belongs to the medical diagnosis auxiliary technology, the protein chip has at least one sub-detection area, each sub-detection area has at least one detection spot, and the detection spots have non-overlapping, dispersedly tiled, non-overlapping, non-overlapping, non-overlapping, non-overlapping, non-overlapping, non-overlapping, non-overlapping, non-overlapping, non-overlapping, non-overlapping and non-overlapping detection spots. The coating density of the capture molecules is 5 * 10 < 10 >-8 * 10 < 10 > per square millimeter; the capture molecule is a mouse monoclonal antibody, and the monoclonal antibody is obtained after a mouse is immunized by taking pneumocystis carbodii separated from human lungs as an antigen.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a medical diagnosis auxiliary technology, and in particular to an ultra-sensitive protein chip and a kit for detecting major glycoproteins of the cell wall of Pneumocystis. Background Art

[0002] Pneumocystis is an opportunistic fungus that can cause severe and fatal Pneumocystis pneumonia in HIV-infected and other immunocompromised patients. The incidence of Pneumocystis pneumonia has gradually increased in recent years. Early detection and diagnosis are conducive to timely treatment and improved prognosis. Serological antigen detection can be used for early diagnosis of fungi and is a rapid clinical diagnostic method for fungal infections.

[0003] Due to the low sensitivity of traditional methods, the content of Pneumocystis antigen in the blood of patients with Pneumocystis pneumonia is low. There are currently no reports on serological antigen detection of Pneumocystis. It is urgent to develop an ultra-sensitive detection method for Pneumocystis antigen for the early diagnosis of Pneumocystis pneumonia.

[0004] Pneumocystis contains a large number of proteins, including major surface glycoprotein, P55 protein, A12 protein, major surface glycoprotein-related antigen protein, Meu10, etc. Major surface glycoprotein is an important component of the cell wall of Pneumocystis, accounting for 3 / 4 of the total protein of Pneumocystis. Its main function is to promote the adhesion of Pneumocystis to the host's alveolar epithelial cells.

[0005] The present invention is an ultra-sensitive protein chip technology, which is applied to the detection of the main glycoproteins of the cell wall of Pneumocystis in serum. The ultra-sensitive protein chip technology can accurately detect the target protein at the picogram level (pg / ml) in the sample to be tested. It will provide an ultra-sensitive, accurate, economical and convenient detection method for serum antigen detection of Pneumocystis pneumonia, which will help solve the key problem of the difficulty in early diagnosis of Pneumocystis pneumonia. Summary of the invention

[0006] Based on the needs of the above-mentioned fields, the present invention provides an ultra-sensitive protein chip and detection kit for the main glycoprotein of the cell wall of Pneumocystis jiroveci. The technical scheme is as follows:

[0007] An ultrasensitive protein chip for detecting the main glycoprotein of the cell wall of Pneumocystis jiroveci, characterized in that the protein chip has at least one sub-detection area, each sub-detection area has at least one detection spot, and the detection spots are non-overlapping and dispersed, with a coating density of 5x10 per square millimeter. 10 ~8x10 10 The capture molecule is a mouse monoclonal antibody, which is obtained by immunizing mice with Pneumocystis carinii isolated from human lungs as an antigen.

[0008] Preferably, the ultrasensitive protein chip is characterized in that the diameter of the detection spot is 3-5 mm.

[0009] Preferably, the ultrasensitive protein chip is characterized in that each sub-detection area is a detection spot, which is a regular or irregular pattern with an area of ​​9-25 mm, preferably a circle with a diameter of 4 mm.

[0010] Preferably, the ultrasensitive protein chip is characterized by having 20-30 sub-detection areas.

[0011] Preferably, the ultrasensitive protein chip is characterized in that a Teflon coating is provided between adjacent sub-detection areas to separate the sub-detection areas and prevent cross contamination between samples.

[0012] Preferably, the ultra-sensitive protein chip is characterized in that, between the sub-detection areas, the monoclonal antibodies for detecting Pneumocystis on the detection spots therein are completely identical to each other; or between at least two sub-detection areas, the monoclonal antibodies for detecting Pneumocystis on the detection spots are different from each other.

[0013] Another aspect of the present invention is a kit for detecting the major glycoprotein of the cell wall of Pneumocystis jiroveci, characterized in that it comprises at least one of the above-mentioned protein chips, as well as HRP-labeled mouse IgGκ binding protein, 0.05% PBS-Tween solution and HRP luminescent substrate solution.

[0014] In another aspect of the present invention, a method for preparing any of the above protein chips is provided, characterized in that it comprises the following steps:

[0015] (1) obtaining a slide having at least one sub-detection area,

[0016] (2) In each sub-detection area, the monoclonal antibody protein molecules of Pneumocystis jiroveci are evenly dispersed and sprayed to form a non-overlapping, dispersed and flat layer with a density of 5×10 per square millimeter. 10 ~8x10 10 The invention discloses a detection spot of the coating density of a capture molecule; the capture molecule is a mouse monoclonal antibody, which is obtained by immunizing mice with Pneumocystis carinii separated from human lungs as an antigen.

[0017] The protein chip of the major glycoprotein of the cell wall of Pneumocystis of the present invention can detect the major glycoprotein of the cell wall of Pneumocystis as low as 1.8 pg / ml quickly and at low cost, providing a powerful detection means for early diagnosis research of Pneumocystis pneumonia and helping to improve the early diagnosis rate of Pneumocystis pneumonia.

[0018] In order to improve the sensitivity, the present invention repeatedly makes precise adjustments to the following items: strictly and precisely adjust the pH value of the captured protein according to the properties of the captured protein Pneumocystis monoclonal antibody; strictly calculate the required number according to the molecular weight of the captured protein to determine the capture density of the captured molecules; precisely adjust the required number of the detection antibody and the HRP-labeled mouse IgGκ binding protein according to their molecular weights; adjust the pH value, temperature, and washing time of the buffer solution; adjust the incubation time and temperature; and adjust various parameters required for signal scanning.

[0019] The capture protein and the detection protein of the present invention are both monoclonal antibodies of Pneumocystis from mice. The HRP-labeled mouse IgGκ binding protein can bind to both the detection antibody and the capture antibody of the detection spot, so false positives will inevitably be generated. In order to avoid the generation of false positives, the detection antibody and the HRP-labeled mouse IgGκ binding protein are pre-incubated, and the two are fully combined to prevent the HRP-labeled mouse IgGκ binding protein from binding to the capture antibody of the detection spot, thereby effectively avoiding the generation of false positives.

[0020] During the research and development, it was found that the independent dispersion arrangement of the capture protein molecules plays a decisive role in improving the detection sensitivity. Through analysis and calculation, the present invention found that a circular detection hole with a diameter of 4 mm has an area of ​​12.56 square millimeters, which can be tiled in a single layer of 1.94x10 12 In order to allow the captured protein molecules on the detection spot to be dispersed with a certain distance from each other, the present invention preliminarily determined that the detection spot was 12.56 mm. 2 About 1x10 12 The capture protein molecules are coated to ensure that the capture protein molecules are independent of each other and do not affect each other, so that a single protein molecule to be tested in the sample can react with a single capture protein molecule on the glass slide to obtain an ideal detection sensitivity; the chip of the present invention is further verified that when the coating density is 5×10 per square millimeter, 10 ~8x10 10 Ideal detection sensitivity can be obtained when there are only one capture molecule. The reaction signal between single protein molecules can be captured, and the corresponding signal can still be detected even if the sample to be tested contains only one target protein molecule.

[0021] The capture protein coating and fixation method of the present invention can use a GeSim ultra-micro sample spot meter (NanoPlotter NP 2.1 / 2.1E) to evenly disperse and fix the capture protein molecules on an aldehyde-based glass slide according to a preset pattern and size, or other instruments and equipment can be used to evenly disperse and coat the capture protein on the glass slide to ensure that the capture protein molecules on the glass slide are evenly dispersed in an array and the capture protein molecules do not affect each other.

[0022] The present invention claims protection for the capture protein dispersed coating fixed on the glass slide coating parameters (i.e. 5x10 per square millimeter 10 ~8x10 10 The dispersed fixation method improves the detection sensitivity. No matter what method is used to disperse and fix the captured protein on the glass slide, the reaction between single protein molecules can be detected, the detection sensitivity can be improved, and the capture protein fixation method reaching the femtogram level is within the scope of protection of the technical requirements.

[0023] The protein chip provided by the present invention has all Pneumocystis monoclonal antibody molecules dispersedly arranged in the detection spot without affecting each other. When the Pneumocystis monoclonal antibody and HRP-labeled mouse IgGκ binding protein that are pre-incubated and fully combined are added during the detection, the sample to be tested has as low as one or several Pneumocystis cell wall main glycoprotein molecules. According to the theory of Poisson distribution, each Pneumocystis monoclonal antibody molecule on the detection spot will capture a Pneumocystis cell wall main glycoprotein molecule or not capture it. The captured Pneumocystis cell wall main glycoprotein molecule is combined with the pre-incubated Pneumocystis monoclonal antibody and HRP-labeled mouse IgGκ binding protein complex, catalyzing the substrate to generate a luminescent signal, and the detection signal can be captured by a CCD camera. Since each captured Pneumocystis cell wall main glycoprotein molecule will generate a signal unit, the corresponding Pneumocystis cell wall main glycoprotein concentration can be calculated according to the intensity of the luminescent signal on each detection spot.

[0024] The present invention provides a simple, easy, economical, rapid, and reliable protein chip method for detecting the main glycoproteins of the cell wall of Pneumocystis. 24 samples can be detected at a time, and the test results can be issued within 40 minutes. The main glycoproteins of the cell wall of Pneumocystis in clinical samples can be qualitatively and quantitatively detected, and the results are accurate and highly sensitive.

[0025] The innovation of the present invention lies in the change of the preparation process, that is, the coating method of capturing proteins on the chip, which greatly improves the sensitivity. Therefore, it is not limited to making a protein chip for detecting the main glycoprotein of the cell wall of Pneumocystis.

[0026] Other advantages of the protein array and kits provided in this study:

[0027] It allows for the simultaneous testing of multiple samples, or multiple repetitions of the same sample, or samples taken at different time points to obtain dynamic values, or simultaneous testing of samples from different patients, to achieve high-throughput and high-sensitivity testing, overall reducing testing costs and improving testing efficiency. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] Figure 1. A schematic plan view of an ultrasensitive protein chip for detecting major glycoproteins in the cell wall of Pneumocystis jiroveci according to the present invention;

[0029] Figure 2 . Schematic diagram of the detection principle of the ultrasensitive protein chip of the main glycoprotein of the cell wall of Pneumocystis jiroveci of the present invention;

[0030] Figure 3 . Scanning diagram of the detection results of the ultrasensitive protein chip of the main glycoprotein of the cell wall of Pneumocystis jiroveci of the present invention. DETAILED DESCRIPTION

[0031] The present invention is further described in detail below in conjunction with specific embodiments, but the scope of the present invention is not limited thereto. Unless otherwise specified, the operations used in the following examples are conventional methods, and the reagents used are

[0032] like Figure 1 As shown, the present invention provides an ultrasensitive protein chip for detecting the main glycoprotein of the cell wall of Pneumocystis, characterized in that the protein chip has at least one sub-detection area, each sub-detection area has at least one detection spot, and the detection spots are non-overlapping and dispersed, with a coating density of 5x10 per square millimeter. 10 -8x10 10 The capture molecule is a mouse monoclonal antibody obtained by immunizing mice with Pneumocystis carinii isolated from human lungs.

[0033] Preferably, the ultrasensitive protein chip is characterized in that the diameter of the detection spot is 3-5 mm.

[0034] Preferably, the ultrasensitive protein chip is characterized in that each sub-detection area is a detection spot, which is a regular or irregular pattern with an area of ​​9-25 mm, preferably a circle with a diameter of 4 mm.

[0035] Preferably, the ultrasensitive protein chip is characterized by having 20-30 sub-detection areas.

[0036] Preferably, the ultrasensitive protein chip is characterized in that a Teflon coating is provided between adjacent sub-detection areas to separate the detection sub-areas and prevent cross contamination between samples.

[0037] Preferably, the ultra-sensitive protein chip is characterized in that, between the sub-detection areas, the Pneumocystis monoclonal antibodies on the detection spots therein are completely identical to each other; or between at least two sub-detection areas, the Pneumocystis monoclonal antibodies on the detection spots are different from each other.

[0038] Example 1. Preparation of ultra-sensitive protein chip of major glycoproteins of Pneumocystis cell wall

[0039] Reagents used:

[0040] Antibodies 1. Product name: Pneumocystis carinii mouse monoclonal antibody IgM (kappa light chain). Pneumocystis carinii antibody (3F6), purchased from Santa Cruz, catalog number sc-57980;

[0041] Partial protein sequence of the main surface glycoprotein of Pneumocystis cell wall GenBank: AAG13994.1, construction of vector, prokaryotic expression of protein

[0042] Antibody 2. Product name: Pneumocystis carinii mouse monoclonal antibody IgMκ, Pneumocystis carinii antibody (4i255), purchased from Santa Cruz, catalog number: sc-71915;

[0043] Mouse IgGκ binding protein-HRP label: m-IgGκBP-HRP 200μg / 0.5ml, purchased from: Santa Cruz Catalog number: sc-516102

[0044] PBS formula: sodium chloride (NaCl) 8g, potassium chloride (KCl) 0.2g, disodium hydrogen phosphate (Na2HPO4) 1.44g, potassium dihydrogen phosphate (KH2PO4) 0.24g, adjust pH to 7.4, constant volume 1L

[0045] PBST formula: 1L PBS, + 1ml Tween-20;

[0046] The chip substrate is a diagnostic glass slide purchased from Japan. Each chip contains 24 detection holes (sub-detection areas) with a diameter of 4 mm. Each detection hole is a detection spot. In the sub-detection area, the detection spots evenly cover the detection holes. Figure 1 .

[0047] Chip preparation process: The capture protein used is: Pneumocystis carinii mouse monoclonal antibody IgM. Pneumocystis carinii antibody (3F6). The capture protein molecules are evenly dispersed and fixed on the aldehyde-based glass slide according to the preset pattern and size using the GeSim ultra-micro sample spotter (NanoPlotter NP 2.1 / 2.1E). The parameters are set so that the coating density is 5x10 per square millimeter. 10 -8x10 10 capture molecules, such as Figure 1 As shown on the right, the Pneumocystis mouse monoclonal antibody IgM protein molecules are dispersed and do not overlap.

[0048] Example 2. Method for using the ultra-sensitive Pneumocystis cell wall major glycoprotein protein chip

[0049] The operation process and principle of the protein chip of the present invention are as follows:

[0050] 1. Pre-incubate antibody 2: Pneumocystis mouse monoclonal antibody IgM, Pneumocystis carinii antibody (4i255), and mouse IgGκ binding protein-HRP labeled, m-IgGκBP-HRP; obtain HRP detection mixture;

[0051] 2. On the chip prepared in Example 1, a portion of the test sample (8ul) was added to each sub-detection area and stored at room temperature for 20 minutes to allow the major glycoprotein of the cell wall of Pneumocystis that may be contained in the sample to bind to the monoclonal antibody IgM of Pneumocystis on the chip;

[0052] 3. Wash the chip with 0.05% PBS-Tween for 5 seconds each time, 5 times to remove non-specific binding;

[0053] 4. Add HRP detection mixture to form a Pneumocystis mouse monoclonal antibody IgM-Pneumocystis cell wall major glycoprotein-Pneumocystis mouse monoclonal antibody IgM-mouse IgGκ binding protein-HRP labeled complex on the chip, such as Figure 2 shown.

[0054] 4. Wash the chip with 0.05% PBS-Tween for 5 seconds each time, 5 times to remove non-specific binding;

[0055] 5. Add horseradish peroxidase luminescent substrate.

[0056] Expected results: If the sample contains the main glycoprotein of the cell wall of Pneumocystis, the test spot will show a luminescent signal; if the sample does not contain the main glycoprotein of the cell wall of Pneumocystis, the test spot will have no signal.

[0057] The results are as follows Figure 3 As shown, a signal can be detected in a serum dilution (sample 1) with a content of major glycoprotein of the Pneumocystis cell wall as low as 1.8 ug / ml.

Claims

1. An ultrasensitive protein chip for detecting the main glycoproteins of the cell wall of Pneumocystis jiroveci. It is characterized in that The protein chip has at least one sub-detection area, each sub-detection area has at least one detection spot, and the detection spots are non-overlapping and dispersed, with a coating density of 5×10 per square millimeter. 10 ~8x10 10 In each sub-detection area, the Pneumocystis monoclonal antibody protein molecules are evenly dispersed and sprayed to form a non-overlapping, dispersed and flat layer with a density of 5x10 per square millimeter. 10 ~8x10 10 The invention discloses a detection spot of the coating density of a capture molecule; the capture molecule is a mouse monoclonal antibody, which is obtained by immunizing mice with Pneumocystis carinii separated from human lungs as an antigen.

2. The ultrasensitive protein chip according to claim 1, It is characterized in that The diameter of the detection spot is 3-5 mm.

3. The ultrasensitive protein chip according to claim 1, It is characterized in that Each sub-detection area is a detection spot, which is a regular or irregular pattern with an area of ​​9-25 mm, preferably a circle with a diameter of 4 mm. The ultrasensitive protein chip according to claim 1 , comprising 20-30 sub-detection areas.

5. The ultrasensitive protein chip according to claim 1, It is characterized in that There is a Teflon coating between adjacent sub-detection areas to separate the sub-detection areas and prevent cross contamination between samples.

6. The ultrasensitive protein chip according to claim 1, It is characterized in that Between the sub-detection areas, the Pneumocystis monoclonal antibodies on the detection spots are completely identical; or between at least two sub-detection areas, the Pneumocystis monoclonal antibodies on the detection spots are different from each other.

7. A kit for detecting the main glycoprotein of the cell wall of Pneumocystis jiroveci, It is characterized in that The invention comprises the ultrasensitive protein chip according to any one of claims 1 to 6, as well as HRP-labeled mouse IgGκ binding protein, 0.05% PBS-Tween solution and HRP luminescent substrate solution.

8. A method for preparing an ultrasensitive protein chip according to any one of claims 1 to 6, It is characterized in that The following steps are involved: (1) obtaining a slide having at least one sub-detection area, (2) In each sub-detection area, the monoclonal antibody protein molecules of Pneumocystis jiroveci are evenly sprayed to form a non-overlapping, dispersed and flat layer with a density of 5×10 per square millimeter. 10 ~8x10 10 The invention discloses a detection spot of the coating density of a capture molecule; the capture molecule is a mouse monoclonal antibody, which is obtained by immunizing mice with Pneumocystis carinii separated from human lungs as an antigen.